Literature DB >> 6220732

Quantitative analysis of T-lymphocyte subsets in atopic eczema, using monoclonal antibodies and flow cytofluorimetry.

C B Zachary, D M MacDonald.   

Abstract

An analysis of T-lymphocyte subpopulations was performed on thirty-eight consecutive patients with atopic eczema, using monoclonal antibodies and flow cytofluorimetry. The total T-lymphocyte and helper T-cell numbers did not differ significantly from those of a matched control group, but there was a highly significant reduction in suppressor T-cell numbers among the atopic group. Both suppressor T-cell deficiency and circulating IgE elevation were found to correlate positively with disease activity. Food specific IgE levels to milk and egg were ascertained by radioallergosorbent (RAST) studies. These proved positive in seven out of thirty-five atopics (20%).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6220732     DOI: 10.1111/j.1365-2133.1983.tb04593.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  4 in total

1.  Decreased monocyte production of interleukin-1 and impaired lymphocyte proliferation in atopic dermatitis.

Authors:  L Räsänen; M Lehto; T Reunala; C Jansen; P Leinikki
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

2.  Soluble interleukin 2 receptor in atopic eczema.

Authors:  G B Colver; J A Symons; G W Duff
Journal:  BMJ       Date:  1989-05-27

3.  Enhanced procoagulant activity of mononuclear leukocytes in patients with atopic dermatitis and psoriasis.

Authors:  R E Schopf; H Weber; B Morsches
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

4.  Itch and inflammation induced by intradermally injected interleukin-2 in atopic dermatitis patients and healthy subjects.

Authors:  C F Wahlgren; M Tengvall Linder; O Hägermark; A Scheynius
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.